A new drug by pharmaceutical giant Eli Lilly rivaling Ozempic and Wegovy could lead to 'significantly' more weight loss after just one year, a trial showcasing initial results has suggested.

San Francisco-based pharmaceutical company OKAVA is investigating an implant that slowly releases a GLP-1 medication for up ...

A new weight-loss treatment for cats, inspired by the popular human drug Ozempic, is currently being tested by veterinarians. OKAVA Pharmaceuticals has announced that its first clinical trial for ...

More than half of the world's pet cats are overweight, experts estimate, and soon, these chubby felines may be treated with a ...